​
Powered by Niramai
Credentials
The Science Behind BreasTest
BreasTest's underlying technology, Niramai was developed with a commitment to scientific validation and clinical excellence. The technology represents years of development and validation. It is commercially available in 22 countries, including India, Philippines, Zambia, Sweden, Bulgaria and UK. We are proud to bring to bring it to the United States withBreastHealth-100 which has US FDA clearance for adjunctive use.
FDA-Cleared Technology
BreasTest is FDA-cleared as an adjunctive diagnostic tool for thermally significant indications in the breast region.
Advanced AI Devleopment
Our artificial intelligence algorithms have been trained and validated to detect subtle thermal patterns that might indicate areas needing attention.
Clinical Validation
Multiple clinical studies have demonstrated the value of our technology in providing meaningful breast health information, particularly for younger women.
Our Commitment to You
We believe every woman deserves access to comfortable, accessible breast health monitoring—regardless of age. BreasTest was created to fill the gap in care for women under 4klk0, providing valuable information years before traditional screening typically begins.
​
Our team includes experts in women's health, artificial intelligence, and medical technology, all united by a common mission: to transform breast health monitoring for younger women.
It's Origin
Dr. Geetha from Niramai discusses the revolutionary AI-led breast cancer screening solution. Discover how Niramai powered by Thermalytix is making a global impact, with availability in countries like Kenya, Sweden, Abu Dhabi, and more. We are now able to make this important AI technology available to women in the United States through BreasTest.
Dr. Geetha addresses the United Nations General Assembly
